Bellevue Group AG - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 202 filers reported holding IMPAX LABORATORIES INC in Q4 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q1 2018$1,459,000
+16.8%
75,0000.0%0.14%
+11.5%
Q4 2017$1,249,000
-29.3%
75,000
-13.8%
0.13%
-29.7%
Q3 2017$1,766,000
-37.3%
87,000
-50.3%
0.18%
-44.4%
Q2 2017$2,818,000
+25.1%
175,000
+84.2%
0.33%
-18.2%
Q3 2016$2,252,000
-17.8%
95,0000.0%0.41%
-21.0%
Q2 2016$2,738,000
-20.8%
95,000
-12.0%
0.52%
-18.0%
Q1 2016$3,458,000108,0000.63%
Other shareholders
IMPAX LABORATORIES INC shareholders Q4 2017
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 560,400$9,022,0003.93%
NORTH TIDE CAPITAL, LLC 1,000,000$16,100,0003.58%
Sivik Global Healthcare LLC 250,000$4,025,0001.47%
MAVERICK CAPITAL LTD 7,159,336$115,265,0001.44%
SECTOR GAMMA AS 589,311$9,488,0001.38%
BRIDGER MANAGEMENT, LLC 1,341,143$21,592,0001.23%
Eos Focused Equity Management, L.P. 48,714$784,0000.89%
Bridge City Capital, LLC 47,194$760,0000.64%
Fosun International Ltd 300,000$4,830,0000.60%
Century Capital Management, LLC 203,138$3,271,0000.56%
View complete list of IMPAX LABORATORIES INC shareholders